Active	Status	Sponsor type	Region	Phase	Filter
1 Active 24 Inactive 25 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   - « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
gaboxadol (OV101) / Ovid Therapeutics, Healx
NCT06334419: Placebo-Controlled, Single-Dose Challenge Study of Gaboxadol in Adult Males With Fragile X Syndrome (FXS)	Recruiting	2	10	US	Gaboxadol, Placebo	Craig Erickson, Healx Limited	Fragile X Syndrome	09/24	09/24
AI platform-based Fragile X Syndrome therapeutic / Healx
No trials found

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
gaboxadol (OV101) / Ovid Therapeutics, Healx
NCT06334419: Placebo-Controlled, Single-Dose Challenge Study of Gaboxadol in Adult Males With Fragile X Syndrome (FXS)	Recruiting	2	10	US	Gaboxadol, Placebo	Craig Erickson, Healx Limited	Fragile X Syndrome	09/24	09/24
AI platform-based Fragile X Syndrome therapeutic / Healx
No trials found